凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體
Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT)
- 編號(hào)MAA831Hu24
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 來源單抗制備
 - 宿主小鼠
 - 效價(jià)(克隆號(hào))C3
 - Ig亞型 IgG1 Kappa
 - 純化方式蛋白A + 蛋白G親和純化
 - 標(biāo)記物無標(biāo)記物
 - 免疫原RPA831Hu01-凝血酶/抗凝血酶復(fù)合體(TAT)重組蛋白
 - 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
 - 性狀液體
 - 濃度1mg/ml
 - 且適物種-
 - 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見流式抗體。 - 下載英文說明書 中文說明書
 - 規(guī)格20μl100μl200μl1ml10ml
 - 價(jià)格¥ 1183¥ 2759¥ 3942¥ 9855¥ 39420
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
該抗體是針對(duì)TAT的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別TAT。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| EPA831Hu61 | 凝血酶/抗凝血酶復(fù)合體(TAT)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA831Hu01 | 凝血酶/抗凝血酶復(fù)合體(TAT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| MAA831Hu21 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB | 
| MAA831Hu24 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA831Hu25 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA831Hu22 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA831Hu23 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA831Hu27 | 凝血酶/抗凝血酶復(fù)合體(TAT)單克隆抗體 | WB; IHC; ICC; IP. | 
| SEA831Hu | 凝血酶/抗凝血酶復(fù)合體(TAT)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMA831Hu | 凝血酶/抗凝血酶復(fù)合體(TAT)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| IUBMB LIFE | Genetic repression of mouse VEGF expression regulates coagulation cascade.[PubMed: 21086498] | 
| Thrombosis Research | Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice[ScienceDirect: S0049384811004166] | 
| Journal of Thrombosis and Haemostasis | High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality[Wiley: source] | 
| 3 | Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling[Nature: 20120329] | 
| Am J Respir Cell Mol Bio | Prolonged Exposure to Sphingosine 1–Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury[PubMed: PMC2993087] | 
| PLoS One | Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis[PubMed: PMC3521733] | 
| Haemetology | Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India[Pubmed: 23992124] | 
| Am J Transl Res. | Selected hemostatic parameters in patients with pancreatic tumors.[Pubmed:Pmc4297344] | 
| PLOS ONE | TFPI1 Mediates Resistance to Doxorubicin in Breast Cancer Cells by Inducing a Hypoxic-Like Response[Pubmed:24489651] | 
| Leukemia | Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs)[Pubmed:24667943] | 
| Anesthesia & Analgesia | Thrombomodulin Improved Liver Injury, Coagulopathy, and Mortality in an Experimental Heatstroke Model in Mice[Pubmed:24781566] | 
| Cell Transplantation | Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood[Pubmed:26087465] | 
| European Journal of Pharmacology | (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coaCavia (Guinea pig )lation[Pubmed:27343380] | 
| J Thromb Haemost. | Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis.[pubmed:27813324] | 
| Blood Cells, Inflammation and Infection | Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury[pubmed:29202212] | 
| SCIENCE TRANSLATIONAL MEDICINE | Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension[pubmed:28148841] | 
| 32 | Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target[pubmed:28289017] | 
| Thrombosis?andHaemostasis | Nebulized anti-coagulants as a therapy for acute lung injury and acute respiratory distress syndrome[Pubmed: 29202212] | 
| Thrombosis Research | The circadian rhythm of selected parameters of the hemostasis system in healthy people[] | 
| Experimental Neurobiology | Transduced Tat-aldose Reductase Protects Hippocampal Neuronal Cells against Oxidative Stress-induced Damage[Pubmed: 31698553] | 
| LIVER TRANSPLANTATION | The impact of dabigatran treatment on sinusoidal protection against hepatic ischemia‐reperfusion injury in mice[Pubmed: 33108682] | 
| Am J Physiol Heart Circ Physiol | Doxorubicin contributes to thrombus formation and vascular injury via enhancing platelet functions in vivo[Pubmed: 32469636] | 
| Intensive Care Medicine Experimental | Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental?…[34169407] | 
| Intensive Care Med Exp | Complement factor D is linked to platelet activation in human and rodent sepsis[34396466] | 



